96
Participants
Start Date
November 30, 2004
Primary Completion Date
January 31, 2007
Study Completion Date
January 31, 2007
S-1
Capecitabine
National Cancer Center, Goyang-si
Hallym University Sacred Heart Hospital, Pyeongchon
Kyung Pook National University Hospital, Daegu
Yeungnam University Medical Center, Daegu
Gacheon Medical School Gil Medical Center, Incheon
Asan Medical Center, Seoul
Korea Cancer Center Hospital, Seoul
Seoul Samsung Medical Center, Seoul
Ulsan University Hospital, Ulsan
Lead Sponsor
Asan Medical Center
OTHER